We, N-Techem International Co., Ltd., have been steadily growing up in the field of pharmaceutical and organic chemical synthesis and fermentation. We have been actively researching and developing the high level of synthesis and fermentation technologies of pharmaceutical and organic chemical bulk substances (especially, cephalosporin finished bulk substances and their key intermediates), then we have been cooperating with the several sound plants (manufacturing pharmaceutical ingredients) located mainly in the Zhejiang province, with whom we have been jointly proceeding on our valuable projects. Meanwhile, we have been managing the stable and strong finance policy controlled by our own N-Techem Hong Kong and China as being closely linked with sound banking monetary system.

We, N-Techem International Co., Ltd., have been performing the systematic marketing activities in the tight union with our strong and credible partners, ACSD in Italy and the other promising customers of the world. And also, we are expanding our marketing promotion into our China domestic territories and the other Asian zone. In the meantime, our N-Techem have started to trade and distribute the general pharmaceutical and chemical products manufactured by the other companies in China closely collaborated with us, which are separately introduced in the column of our 'PRODUCT". In the aforementioned background of our activities, we have entered the cosmetic and detergent field with our own brand Multi-bebe products, also we have recently started to perform IVD (In Vitro Diagnosis) projects at exclusive sales system with IVD's manufacturer, RepoDx in Nantong of China.

We, N-Techem International Co., Ltd., have been and will be doing our best for providing our all customers with the high quality bulk substances produced strictly in accordance with their standard specifications. Meanwhile, our independent R&D center and overseas marketing offices have been always supporting us with their latest updated technical knowledge and the valuable marketing information, so that we can effectively perform all our activities concerned with our technology development, preparation of the Drug Master File (DMF), process of the related registrations & etc.